These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18513512)

  • 1. Renal effects of ularitide in patients with decompensated heart failure.
    Lüss H; Mitrovic V; Seferovic PM; Simeunovic D; Ristić AD; Moiseyev VS; Forssmann WG; Hamdy AM; Meyer M
    Am Heart J; 2008 Jun; 155(6):1012.e1-8. PubMed ID: 18513512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.
    Mitrovic V; Lüss H; Nitsche K; Forssmann K; Maronde E; Fricke K; Forssmann WG; Meyer M
    Am Heart J; 2005 Dec; 150(6):1239. PubMed ID: 16338265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and clinical effects of ularitide in decompensated heart failure.
    Mitrovic V; Seferovic PM; Simeunovic D; Ristic AD; Miric M; Moiseyev VS; Kobalava Z; Nitsche K; Forssmann WG; Lüss H; Meyer M
    Eur Heart J; 2006 Dec; 27(23):2823-32. PubMed ID: 17074775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of the natriuretic peptide ularitide in acute renal failure.
    Meyer M; Pfarr E; Schirmer G; Uberbacher HJ; Schöpe K; Böhm E; Flüge T; Mentz P; Scigalla P; Forssmann WG
    Ren Fail; 1999 Jan; 21(1):85-100. PubMed ID: 10048120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
    Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
    Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.
    Brenner P; Meyer M; Reichenspurner H; Meiser B; Müller R; Mentz P; Schulz-Knappe P; Uberbacher HJ; Kreuzer E; Uberführ P
    Eur J Med Res; 1995 Dec; 1(3):137-43. PubMed ID: 9389675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery--a randomized controlled trial.
    Herbert MK; Ginzel S; Mühlschlegel S; Weis KH
    Wien Klin Wochenschr; 1999 Feb; 111(4):141-7. PubMed ID: 10192146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide).
    Wiebe K; Meyer M; Wahlers T; Zenker D; Schulze F; Michels P; Dalichau H; Mohr FW; Borst H; Forssmann WG
    Eur J Med Res; 1996 Feb; 1(5):259-65. PubMed ID: 9374447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL; Peng JT; Okamoto MP; Heywood JT
    Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.
    Anker SD; Ponikowski P; Mitrovic V; Peacock WF; Filippatos G
    Eur Heart J; 2015 Mar; 36(12):715-23. PubMed ID: 25670819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    Packer M; O'Connor C; McMurray JJV; Wittes J; Abraham WT; Anker SD; Dickstein K; Filippatos G; Holcomb R; Krum H; Maggioni AP; Mebazaa A; Peacock WF; Petrie MC; Ponikowski P; Ruschitzka F; van Veldhuisen DJ; Kowarski LS; Schactman M; Holzmeister J;
    N Engl J Med; 2017 May; 376(20):1956-1964. PubMed ID: 28402745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodilatin, a new therapy to prevent kidney failure after heart transplantation.
    Hummel M; Kuhn M; Bub A; Mann B; Schneider B; von Eickstedt KW; Forssmann WG; Hetzer R
    J Heart Lung Transplant; 1993; 12(2):209-17; discussion 217-8. PubMed ID: 8476893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.